In this webinar, Dr. Smoller describes the current status of psychiatric genetic research with a focus on depressive and anxiety disorders. Dr. Smoller reviews implications of this work for clinical practice, including the prospects and limitations of genetic or pharmacogenetic testing. He describes the potential for extending a precision medicine approach to the realm of depression and anxiety disorders.
At the end of this session, participants will be able to:
- Summarize progress in identifying the genetic basis of psychiatric disorders;
- Understand the implications of psychiatric genetics for clinical practice
- Discuss the current status of pharmacogenetic testing for psychiatric drug use.
This webinar is sponsored by the Genetics and Neuroscience Special Interest Group.
Dr. Jordan Smoller is the MGH Trustees Endowed Chair in Psychiatric Neuroscience, Professor of Psychiatry at Harvard Medical School and Professor in the Department of Epidemiology at the Harvard School of Public Health in Boston. He is Associate Chief for Research in the MGH Department of Psychiatry and Director of the Psychiatric and Neurodevelopmental Genetics Unit in the MGH Center for Genomic Medicine. Dr. Smoller is a Tepper Family MGH Research Scholar and also serves as Director of the Omics Unit of the MGH Division of Clinical Research and co-Director of the Partners HealthCare Biobank at MGH. He is a Principal Investigator of All of Us New England as part of the NIH All of Us Research Program. Dr. Smoller is an author of more than 300 scientific publications and is also the author of The Other Side of Normal (HarperCollins/William Morrow, 2012).